K-645

· Kallyope Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K-645, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of K-645 in the Treatment of Multiple Migraine Attacks [Phase 2]